- Politics
- Diversity, equity and inclusion
- Financial Decision Making
- Telehealth
- Patient Experience
- Leadership
- Point of Care Tools
- Product Solutions
- Management
- Technology
- Healthcare Transformation
- Data + Technology
- Safer Hospitals
- Business
- Providers in Practice
- Mergers and Acquisitions
- AI & Data Analytics
- Cybersecurity
- Interoperability & EHRs
- Medical Devices
- Pop Health Tech
- Precision Medicine
- Virtual Care
- Health equity
HIMSS 2024 in 2 Minutes: The top stories
Tens of thousands came to the HIMSS Conference in Orlando, and AI and cybersecurity dominated the conversation.
Orlando, Florida – The HIMSS Global Health Conference & Exhibition drew more than 30,000 attendees and featured hundreds of discussions, so how do you sum it up in two minutes?
Well, we won’t cover all the nuances, but this video review does provide a synopsis of the two dominant themes: AI and cybersecurity.
The conference featured discussions covering varying aspects of the industry, including interoperability and digital health. But as the conference wraps up today, it’s safe to say that AI and cybersecurity generated the most discussion.
Hackensack Meridian Health CEO Robert Garrett talked about AI’s potential to improve the health of billions worldwide. Experts also said AI tools could ease burdens on clinicians. Many also talked about the need to ensure appropriate ethical considerations in expanding the use of AI.
With the Change Healthcare cyberattack affecting providers, cybersecurity loomed as an even bigger topic. Cybersecurity experts also talked about the growing danger of cyberattacks, which have become disturbingly common in healthcare even before the Change Healthcare attack.
Here’s a look at some insights, and at least some of the sights, from a memorable HIMSS conference.
Hospitals continue to struggle with IV fluid shortage, with some still delaying surgeries
November 25th 2024Some health systems have developed conservation strategies, and Baxter International has resumed production at its North Carolina plant. But some facilities are still facing serious challenges.
